Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

24 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A prospective study of cellular immune response to booster COVID-19 vaccination in multiple sclerosis patients treated with a broad spectrum of disease-modifying therapies.
Torres P, Sancho-Saldaña A, Gil Sánchez A, Peralta S, Solana MJ, Bakkioui S, González-Mingot C, Quibus L, Ruiz-Fernández E, San Pedro-Murillo E, Brieva L. Torres P, et al. Among authors: gil sanchez a. J Neurol. 2023 May;270(5):2380-2391. doi: 10.1007/s00415-023-11575-8. Epub 2023 Mar 18. J Neurol. 2023. PMID: 36933032 Free PMC article.
Impairment of Mitochondrial Redox Status in Peripheral Lymphocytes of Multiple Sclerosis Patients.
Gonzalo H, Nogueras L, Gil-Sánchez A, Hervás JV, Valcheva P, González-Mingot C, Martin-Gari M, Canudes M, Peralta S, Solana MJ, Pamplona R, Portero-Otin M, Boada J, Serrano JCE, Brieva L. Gonzalo H, et al. Among authors: gil sanchez a. Front Neurosci. 2019 Sep 4;13:938. doi: 10.3389/fnins.2019.00938. eCollection 2019. Front Neurosci. 2019. PMID: 31551694 Free PMC article.
Seroprevalence of SARS-CoV-2 in a Cohort of Patients with Multiple Sclerosis under Disease-Modifying Therapies.
Sancho-Saldaña A, Gil Sánchez A, Quirant-Sánchez B, Nogueras L, Peralta S, Solana MJ, González-Mingot C, Gallego Y, Quibus L, Ramo-Tello C, Presas-Rodríguez S, Martínez-Cáceres E, Torres P, Hervás JV, Valls J, Brieva L. Sancho-Saldaña A, et al. Among authors: gil sanchez a. J Clin Med. 2022 Apr 29;11(9):2509. doi: 10.3390/jcm11092509. J Clin Med. 2022. PMID: 35566632 Free PMC article.
Preventive treatment can reverse cognitive impairment in chronic migraine.
González-Mingot C, Gil-Sánchez A, Canudes-Solans M, Peralta-Moncusi S, Solana-Moga MJ, Brieva-Ruiz L. González-Mingot C, et al. Among authors: gil sanchez a. J Headache Pain. 2022 Sep 15;23(1):121. doi: 10.1186/s10194-022-01486-w. J Headache Pain. 2022. PMID: 36109696 Free PMC article.
Prophylactic treatment can modify vascular risk biomarkers in high-frequency episodic and chronic migraine patients: a pilot study.
González Mingot C, Santos Lasaosa S, Colàs Campàs L, Chilangua Canaval L, Gil Sánchez A, Brieva Ruiz L, Marzo Alonso MC, Peralta Moncusi S, Valls Marsal J, Cambray Carner S, Purroy García F. González Mingot C, et al. Among authors: gil sanchez a. Sci Rep. 2023 Nov 8;13(1):19416. doi: 10.1038/s41598-023-44522-8. Sci Rep. 2023. PMID: 37940678 Free PMC article.
Seroprevalence of SARS-CoV-2 in Patients with Multiple Sclerosis under Disease-Modifying Therapies: A Multi-Centre Study.
Sancho-Saldaña A, Gil-Sánchez A, González-Mingot C, Peralta S, Solana MJ, Torres P, Juanes A, Quibus L, Ruiz E, Sanpedro E, Quirant-Sánchez B, Martínez-Cáceres E, Ramo Tello C, Presas-Rodríguez S, García Rubio S, Baron BP, Ramió-Torrentà L, Sotoca J, González-Suárez I, Eichau S, Prieto-González JM, Blasco Quilez MR, Sabín-Muñoz J, Sánchez-López AJ, Llorens Calatayud G, Calles C, Sempere ÁP, Garcés M, Carmona O, Moral E, Hervás JV, Blanco Y, Sola-Valls N, Tellez Lara N, Forero L, Brieva L. Sancho-Saldaña A, et al. Among authors: gil sanchez a. J Clin Med. 2023 Nov 23;12(23):7243. doi: 10.3390/jcm12237243. J Clin Med. 2023. PMID: 38068295 Free PMC article.
24 results